Effects of dietary retinoids upon growth and differentiation of tumors derived from several murine embryonal carcinoma cell linesMCCUE, P. A; THOMAS, R. S; SCHROEDER, D et al.Cancer research (Baltimore). 1988, Vol 48, Num 13, pp 3772-3779, issn 0008-5472Article

Changes in protein synthetic profiles during retinoic-acid induction of differentiation of murine embryonal carcinoma cellsSCHINDLER, J; SHERMAN, M. I.Differentiation (London). 1984, Vol 28, Num 1, pp 78-85, issn 0301-4681Article

Retinoid-binding proteins in embryonal carcinoma cellsGRIPPO, J. F; SHERMAN, M. I.Methods in enzymology. 1990, Vol 190, pp 148-155, issn 0076-6879, 8 p.Article

Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon-α_2aITRI, L. M; SHERMAN, M. I; PALLERONI, A. V et al.Journal of interferon research. 1989, Vol 9, pp S9-S15, issn 0197-8357, suppl. 1Conference Paper

Differential uptake, binding, and metabolism of retinol and retinoic acid by 10T1/2 cellsRUNDHAUG, J; GUBLER, M. L; SHERMAN, M. I et al.Cancer research (Baltimore). 1987, Vol 47, Num 21, pp 5637-5643, issn 0008-5472Article

Tumor suppressor genes: prospects for cancer therapies: should therapy be aimed at restoring normal phenotype to cancer cells or at eliminating the cells altogether?BERTELSEN, A. H; BEAUDRY, G. A; STOLLER, T. J et al.Bio/technology (New York, N.Y. 1983). 1995, Vol 13, Num 2, pp 127-131, issn 0733-222XArticle

Metabolism of retinoic acid and retinol by intact cells and cell extractsGUBLER, M. L; SHERMAN, M. I.Methods in enzymology. 1990, Vol 189, pp 525-530, issn 0076-6879, 6 p.Article

Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cellsNERVI, C; GRIPPO, J. F; SHERMAN, M. I et al.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 15, pp 5854-5858, issn 0027-8424, 5 p.Article

Effects of arotinoids upon murine embryonal carcinoma cells = Effets des arotinoïdes sur les cellules d'un carcinome embryonnaire murinSHERMAN, M. I; PATERNOSTER, M. L; TAKETO, M et al.Cancer research (Baltimore). 1983, Vol 43, Num 9, pp 4283-4290, issn 0008-5472Article

Discovery and characterization of an HIV-I tat antagonist : Novel approaches in HIV chemotherapyMING-CHU HSU; SCHUTT, A. D; HOLLY, M et al.Biochemical Society transactions. 1992, Vol 20, Num 2, pp 525-531, issn 0300-5127Conference Paper

Prevention and therapy of tumors with arotinoidsSHERMAN, M. I; TRUITT, G. A.European journal of cancer & clinical oncology. 1988, Vol 24, Num 3, pp 359-362, issn 0277-5379Article

Isolation of embryonal carcinoma cell lines that express integrated recombinant genes flanked by the moloney murine leukemia virus long terminal repeatTAKETO, M; GILBOA, E; SHERMAN, M. I et al.Proceedings of the National Academy of Sciences of the United States of America. 1985, Vol 82, Num 8, pp 2422-2426, issn 0027-8424Article

Complementation analyses of differentiation-defective embryonal carcinoma cellsMCCUE, P. A; GUBLER, M. L; MAFFEI, L et al.Developmental biology (Print). 1984, Vol 103, Num 2, pp 399-408, issn 0012-1606Article

Murine embryonal carcinoma cells differentiale in vitro in response to retinolEGLITIS, M. A; SHERMAN, M. I.Experimental cell research. 1983, Vol 146, Num 2, pp 289-296, issn 0014-4827Article